Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.

Autor: Seeberg KA; Morbid Obesity Center and Department of Medicine, Vestfold Hospital Trust, Tønsberg, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (K.A.S.)., Borgeraas H; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway (H.B., J.K.H.)., Hofsø D; Morbid Obesity Center and Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway (D.H.)., Småstuen MC; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, and Department of Nursing and Health Promotion, Oslo Metropolitan University, Oslo, Norway (M.C.S.)., Kvan NP; Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway (N.P.K., J.O.G.)., Grimnes JO; Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway (N.P.K., J.O.G.)., Lindberg M; Department of Laboratory Medicine, Vestfold Hospital Trust, Tønsberg, Norway (M.L.)., Fatima F; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway (F.F.)., Seeberg LT; Department of Surgery, Vestfold Hospital Trust, Tønsberg, Norway (L.T.S.)., Sandbu R; Morbid Obesity Center and Department of Surgery, Vestfold Hospital Trust, Tønsberg, Norway (R.S.)., Hjelmesæth J; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, and Department of Endocrinology, Morbid Obesity and Preventive Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway (J.H.)., Hertel JK; Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway (H.B., J.K.H.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2022 Jan; Vol. 175 (1), pp. 74-83. Date of Electronic Publication: 2021 Nov 30.

Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.

Autor: Hugenschmidt H; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. harald@hugenschmidt.net.; Department of Transplantation Surgery, Oslo University Hospital, PO.Box 4950, NO-0424, Oslo, Nydalen, Norway. harald@hugenschmidt.net.; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway. harald@hugenschmidt.net., Labori KJ; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway., Brunborg C; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Verbeke CS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Seeberg LT; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway.; Department of Gastrointestinal Surgery, Vestfold Hospital Trust, Tønsberg, Norway., Bendigtsen Schirmer C; Department of Pathology, Oslo University Hospital, Oslo, Norway., Renolen A; Department of Pathology, Oslo University Hospital, Oslo, Norway., Borgen E; Department of Pathology, Oslo University Hospital, Oslo, Norway., Naume B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Deparment of Oncology, Oslo University Hospital, Oslo, Norway., Wiedswang G; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway.

Publikováno v: BMC cancer [BMC Cancer] 2020 Nov 16; Vol. 20 (1), pp. 1107. Date of Electronic Publication: 2020 Nov 16.

Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.

Autor: Hugenschmidt H; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Transplantation Surgery, Division of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.; Department of GI-Surgery, Division of Surgery and Oncology, Oslo University Hospital, Oslo, Norway., Labori KJ; Department of GI-Surgery, Division of Surgery and Oncology, Oslo University Hospital, Oslo, Norway., Brunborg C; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway., Verbeke CS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Seeberg LT; Department of GI-Surgery, Division of Surgery and Oncology, Oslo University Hospital, Oslo, Norway.; Department of Gastrointestinal Surgery, Vestfold Hospital Trust, Tønsberg, Norway., Schirmer CB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Renolen A; Department of Pathology, Oslo University Hospital, Oslo, Norway., Borgen EF; Department of Pathology, Oslo University Hospital, Oslo, Norway., Naume B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Wiedswang G; Department of GI-Surgery, Division of Surgery and Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Annals of surgery [Ann Surg] 2020 Mar; Vol. 271 (3), pp. 549-558.

The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.

Autor: Angeles PC; Morbid Obesity Centre, Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Surgery, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Robertsen I; Section of Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway., Seeberg LT; Department of Surgery, Vestfold Hospital Trust, Tønsberg, Norway., Krogstad V; Section of Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway., Skattebu J; Library of Health Sciences, Vestfold Hospital Trust, Tønsberg, Norway., Sandbu R; Morbid Obesity Centre, Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Surgery, Vestfold Hospital Trust, Tønsberg, Norway., Åsberg A; Section of Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.; Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway., Hjelmesaeth J; Morbid Obesity Centre, Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Obesity reviews : an official journal of the International Association for the Study of Obesity [Obes Rev] 2019 Sep; Vol. 20 (9), pp. 1299-1311. Date of Electronic Publication: 2019 Jun 24.